Works matching DE "DABIGATRAN"

Results: 481

Dental management of patients taking antiplatelet, oral anticoagulant and novel anticoagulant medications.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2019, v. 76, n. 6, p. 635, doi. 10.2298/VSP170719128B

By:

Bajkin, Branislav;
Mirković, Siniša;
Vučinić, Predrag;
Vučković, Biljana;
Marjanović, Marjan

Publication type:

Article

The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France.

Published in:

2020

By:

de Pouvourville, Gérard;
Blin, Patrick;
Karam, Pierre

Publication type:

journal article

Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases.

Published in:

Journal of Liposome Research, 2019, v. 29, n. 4, p. 399, doi. 10.1080/08982104.2019.1576732

By:

Abouhussein, Dalia M. N.;
Bahaa El Din Mahmoud, Dina;
Mohammad F., Ebtehal

Publication type:

Article

Effects of Oral Anticoagulant Therapy on Gene Expression in Crosstalk between Osteogenic Progenitor Cells and Endothelial Cells.

Published in:

Journal of Clinical Medicine, 2019, p. 329, doi. 10.3390/jcm8030329

By:

Dalle Carbonare, Luca;
Mottes, Monica;
Brunelli, Anna;
Deiana, Michela;
Cheri, Samuele;
Suardi, Silvia;
Valenti, Maria Teresa

Publication type:

Article

Novel anticoagulants in the management of atrial fibrillation: A comprehensive comparative analysis.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.555.e113097

By:

Jwaid, Mazen M.;
Alwan, Mohammed J.;
Ihsan, Isam;
Jwaid, Maher M.;
Muhsin, Yasir F.;
Al-hussaniy, Hany A.;
Al iraqi, Mohammed K.

Publication type:

Article

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran.

Published in:

2024

By:

Kawada, Yu;
Katori, Nobuyuki;
Kaji, Keiko;
Fujioka, Shoko;
Yamaguchi, Tomoki

Publication type:

Case Study

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits.

Published in:

Open Life Sciences, 2022, v. 17, n. 1, p. 1, doi. 10.1515/biol-2022-0002

By:

Yin, Lu;
Qi, Yuan;
Ge, Zhiru;
Li, Jiajin

Publication type:

Article

Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 440, doi. 10.1111/bcpt.13517

By:

Rottenkolber, Marietta;
Schmiedl, Sven;
Ibánez, Luisa;
Sabaté, Mònica;
Ballarín, Elena;
Vidal, Xavier;
Leon‐Muñoz, Luz María;
Huerta, Consuelo;
Martin Merino, Elisa;
Montero, Dolores;
Gasse, Christiane;
Andersen, Morten;
Aakjær, Mia;
De Bruin, Marie Louise;
Gerlach, Roman;
Tauscher, Martin;
Souverein, Patrick C.;
Ham, Rianne;
Klungel, Olaf;
Gardarsdottir, Helga

Publication type:

Article

Fatal Adverse Event with Dabigatran in Elderly Patient with Reduced Kidney Function.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 2, p. 221, doi. 10.1111/bcpt.12985

By:

Havig, Stine Marie;
Lea, Dordi;
Krpo, Maja;
Skari, Ragnhild Margrete;
Gustavsen, Ingebjørg;
Høiseth, Gudrun

Publication type:

Article

Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2017, v. 120, n. 4, p. 407, doi. 10.1111/bcpt.12696

By:

Rosenberg, Lene;
Gerstrøm, Gustav;
Nybo, Mads

Publication type:

Article

Dabigatran Concentration: Variability and Potential Bleeding Prediction In 'Real-Life' Patients With Atrial Fibrillation.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2015, v. 117, n. 5, p. 323, doi. 10.1111/bcpt.12417

By:

Šinigoj, Petra;
Malmström, Rickard E.;
Vene, Nina;
Rönquist‐Nii, Yuko;
Božič‐Mijovski, Mojca;
Pohanka, Anton;
Antovic, Jovan P.;
Mavri, Alenka

Publication type:

Article

Frequency and cost of acute surgical admissions in over‐anticoagulated patients: over‐anticoagulation in the community.

Published in:

ANZ Journal of Surgery, 2018, v. 88, n. 4, p. 301, doi. 10.1111/ans.13851

By:

Nimmo, Moea;
Armstrong, Delwyn;
Koea, Jonathan B.

Publication type:

Article

Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report.

Published in:

Annals of Clinical & Translational Neurology, 2016, v. 3, n. 11, p. 889, doi. 10.1002/acn3.346

By:

Mutzenbach, Johannes Sebastian;
Pikija, Slaven;
Otto, Ferdinand;
Halwachs, Ursula;
Weymayr, Friedrich;
Sellner, Johann

Publication type:

Article

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.626063

By:

Zhou, Ya;
Yao, Zhihao;
Zhu, Linjie;
Tang, Yong;
Chen, Jie;
Wu, Jianming

Publication type:

Article

Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.563920

By:

Li, Xiaoye;
Jin, Qinchun;
Zhang, Xiaochun

Publication type:

Article

Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithm.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 2, p. 712, doi. 10.1093/ckj/sfaa011

By:

Galassi, Andrea;
Podda, Gianmarco;
Monciino, Paola;
Stucchi, Andrea;
Nero, Alberto Del;
Cozzolino, Mario

Publication type:

Article

Dabigatran in the management of livedoid vasculopathy.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 2, p. 237, doi. 10.1111/ced.13022

By:

Sawada, T.;
Suehiro, M.

Publication type:

Article

Idarucizumab in High-risk Thoracic Surgery.

Published in:

2018

By:

López-Vilella, R.;
Sanz-Sánchez, J.;
Sánchez-Lázaro, I.;
Marques-Sule, E.;
Rueda-Soriano, J.;
Almenar-Bonet, L.

Publication type:

Case Study

Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists - the RIC-ICH study.

Published in:

Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1212495

By:

Kuklik, Nils;
Hüsing, Anika;
Stang, Andreas;
Brinkmann, Marcus;
Eschenfelder, Christoph C.;
Weimar, Christian;
Diener, Hans-Christoph

Publication type:

Article

ID 42. Assessing Adherence to Direct Oral Anticoagulants (DOACs) Among Patients with Atrial Fibrillation in Tertiary-Care Referral Centres in Malaysia.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. 866

By:

Kubas, Mohammed A.;
Shabaruddin, Fatiha Hana;
Mazlan-Kepli, Wardati;
Jagan, Nirmala;
Mohamed, Sahimi;
Nazar, Nor Ilyani Mohamed;
Zin, Che Suraya

Publication type:

Article

Assessing Adherence and Persistence to Non-vitamin K Antagonist Oral Anticoagulants (NOACs) among Patients with Atrial Fibrillation in Tertiary-care Referral Centers in Malaysia.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. S781, doi. 10.4103/jpbs.JPBS_381_19

By:

Kubas, Mohammed A.;
Shabaruddin, Fatiha Hana;
Mazlan-Kepli, Wardati;
Jagan, Nirmala;
Mohamed, Sahimi;
Nazar, Nor Ilyani Mohamed;
Zin, Che Suraya

Publication type:

Article

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™.

Published in:

Vascular Medicine, 2016, v. 21, n. 6, p. 506, doi. 10.1177/1358863X16668588

By:

Goldhaber, Samuel Z.;
Eriksson, Henry;
Kakkar, Ajay;
Schellong, Sebastian;
Feuring, Martin;
Fraessdorf, Mandy;
Kreuzer, Joerg;
Schueler, Elke;
Schulman, Sam

Publication type:

Article

Comparing Safety and Efficacy of Dabigatran and Factor Xa Inhibitors for Stroke Prevention in Hemophiliacs with Non-Valvular Atrial Fibrillation.

Published in:

JAFIB: Journal of Atrial Fibrillation, 2019, v. 12, n. 4, p. 1, doi. 10.4022/jafib.2257

By:

Khan, Safeera;
Krishnaswamy, Ratna;
Malik, Bilal Haider;
Islam, Muhammad;
Gupta, Deepti;
Mandal, Shrawan Kumar;
Rutkofsky, Ian H.

Publication type:

Article

A Comparison Between Dabigatran and Warfarin on Time to Elective Cardioversion.

Published in:

JAFIB: Journal of Atrial Fibrillation, 2016, v. 8, n. 6, p. 45

By:

Basto, Amanda N.;
Fewel, Nathan P.;
Gupta, Rajiv;
Stock, Eileen M.;
Mia Ta

Publication type:

Article

Cost-Effectiveness of Dabigatran Exilate in Treatment of Atrial Fibrillation.

Published in:

JAFIB: Journal of Atrial Fibrillation, 2015, v. 7, n. 6, p. 5

By:

Galvani, Giovanni;
Grassetto, Alberto;
Sterlicchio, Stefania;
Themistoclakis, Sakis;
Venturini, Andrea;
Zoffoli, Giampaolo;
Mangino, Domenico

Publication type:

Article

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.

Published in:

PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213614

By:

Amin, Alpesh;
Garcia Reeves, Alessandra B.;
Li, Xiaoyan;
Dhamane, Amol;
Luo, Xuemei;
Di Fusco, Manuela;
Nadkarni, Anagha;
Friend, Keith;
Rosenblatt, Lisa;
Mardekian, Jack;
Pan, Xianying;
Yuce, Huseyin;
Keshishian, Allison

Publication type:

Article

Rivaroxaban administration after acute ischemic stroke: The RELAXED study.

Published in:

PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212354

By:

Yasaka, Masahiro;
Minematsu, Kazuo;
Toyoda, Kazunori;
Mori, Etsuro;
Hirano, Teruyuki;
Hamasaki, Toshimitsu;
Yamagami, Hiroshi;
Nagao, Takehiko;
Yoshimura, Shinichi;
Uchiyama, Shinichiro;
null, null

Publication type:

Article

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.

Published in:

PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0209350

By:

Grottke, Oliver;
van Ryn, Joanne;
Zentai, Christian;
Gan, Guanfa;
Honickel, Markus;
Rossaint, Rolf;
ten Cate, Hugo;
Spronk, Henri M. H.

Publication type:

Article

Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.

Published in:

PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0202575

By:

Gulati, Sasha;
Solheim, Ole;
Carlsen, Sven M.;
Øie, Lise R.;
Jensberg, Heidi;
Gulati, Agnete M.;
Madsbu, Mattis A.;
Giannadakis, Charalampis;
Jakola, Asgeir S.;
Salvesen, Øyvind

Publication type:

Article

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.

Published in:

PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0195950

By:

Lip, Gregory Y. H.;
Pan, Xianying;
Kamble, Shital;
Kawabata, Hugh;
Mardekian, Jack;
Masseria, Cristina;
Phatak, Hemant

Publication type:

Article

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.

Published in:

PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193912

By:

Charlton, Blake;
Adeboyeje, Gboyega;
Barron, John J.;
Grady, Deborah;
Shin, Jaekyu;
Redberg, Rita F.

Publication type:

Article

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.

Published in:

JGIM: Journal of General Internal Medicine, 2022, v. 37, n. 12, p. 2982, doi. 10.1007/s11606-021-07114-8

By:

Huang, Cheng-Wei;
Duan, Lewei;
An, Jaejin;
Sim, John J.;
Lee, Ming-Sum

Publication type:

Article

The pharmacokinetics of dabigatran in a rat model of hyperlipidaemia induced by poloxamer 407.

Published in:

Xenobiotica, 2024, v. 54, n. 9, p. 723, doi. 10.1080/00498254.2024.2404168

By:

Kim, Ji Hyeon;
Baek, Eugene;
Kang, Hee Eun

Publication type:

Article

In vivo evaluation of pharmacokinetic drug–drug interactions between fluorinated pyrimidine anticancer drugs, 5-fluorouracil and capecitabin, and an anticoagulant, warfarin.

Published in:

Xenobiotica, 2022, v. 52, n. 6, p. 608, doi. 10.1080/00498254.2022.2118643

By:

Hasegawa, Ai;
Tsujiya, Yoshie;
Ueda, Ayaka;
Yamamori, Motohiro;
Okamura, Noboru

Publication type:

Article

Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.

Published in:

Xenobiotica, 2019, v. 49, n. 9, p. 1001, doi. 10.1080/00498254.2018.1524188

By:

Ota, Miki;
Notsu, Yuki;
Shimizu, Makiko;
Yamazaki, Hiroshi;
Yamazaki-Nishioka, Miho;
Kogiku, Minoru;
Noda, Masayuki;
Endo, Sumio;
Takekawa, Mitsuru;
Kishi, Hirohisa

Publication type:

Article

New cross‐linkable poly[bis(octafluoropentoxy) phosphazene] biomaterials: Synthesis, surface characterization, bacterial adhesion, and plasma coagulation responses.

Published in:

Journal of Biomedical Materials Research, Part B: Applied Biomaterials, 2020, v. 108, n. 8, p. 3250, doi. 10.1002/jbm.b.34662

By:

Xu, Li‐Chong;
Chen, Chen;
Zhu, Jieru;
Tang, Meixian;
Chen, Andy;
Allcock, Harry R.;
Siedlecki, Christopher A.

Publication type:

Article

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

Published in:

Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2017, v. 17, n. 5, p. 353, doi. 10.14744/AnatolJCardiol.2016.7472

By:

Altay, Servet;
Yıldırımtürk, Özlem;
Çakmak, Hüseyin Altuğ;
Aşkın, Lütfü;
Sinan, Ümit Yaşar;
Beşli, Feyzullah;
Gedikli, Ömer;
Tok, Özge Özden

Publication type:

Article

review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

Published in:

Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2015, v. 15, n. 12, p. 1020, doi. 10.5152/AnatolJCardiol.2015.6532

By:

Güler, Ekrem;
Güler, Gamze Babur;
Demir, Gültekin Günhan;
Hatipoğlu, Suzan

Publication type:

Article

Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study.

Published in:

PLoS Medicine, 2024, v. 21, n. 7, p. 1, doi. 10.1371/journal.pmed.1004400

By:

Bosch, Floris;
Horváth-Puhó, Erzsébet;
Cannegieter, Suzanne C.;
van Es, Nick;
Sørensen, Henrik T.

Publication type:

Article

Spontaneous sublingual hematoma due to warfarin: An emergency presenting to the dermatologist.

Published in:

2016

By:

Kumar Ghosh, Sudip;
Majumder, Biswajit;
Agarwal, Megha;
Rudra, Olympia;
Ghosh, Sudip Kumar

Publication type:

Case Study

Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.

Published in:

Pharmacotherapy, 2018, v. 38, n. 1, p. 6, doi. 10.1002/phar.2046

By:

Maura, Géric;
Billionnet, Cécile;
Alla, François;
Gagne, Joshua J.;
Pariente, Antoine

Publication type:

Article

Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.

Published in:

2016

By:

Li, Pei-Jun;
Xiao, Jun;
Yang, Qing;
Feng, Yuan;
Wang, Ting;
Liu, Guan-Jian;
Liang, Zong-An

Publication type:

journal article

Carbon-13 and carbon-14 labeled dabigatran etexilate and tritium labeled dabigatran.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 14, p. 648, doi. 10.1002/jlcr.3402

By:

Latli, Bachir;
Kiesling, Ralf;
Aßfalg, Stefan;
Chevliakov, Max;
Hrapchak, Matt;
Campbell, Scot;
Gonnella, Nina;
Busacca, Carl A.;
Senanayake, Chris H.

Publication type:

Article

American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period.

Published in:

Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 2, p. 100, doi. 10.1093/jcag/gwac010

By:

Abraham, Neena S;
Barkun, Alan N;
Sauer, Bryan G;
Douketis, James;
Laine, Loren;
Noseworthy, Peter A;
Telford, Jennifer J;
Leontiadis, Grigorios I

Publication type:

Article

Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.

Published in:

2018

By:

Martin, Jack L.;
Esmaeili, Habib;
Manuel, Raymond C.;
Petrini, Michaela;
Wiebe, Sabrina;
Maas, Hugo

Publication type:

journal article

Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.

Published in:

2018

By:

Elewa, Hazem;
El-Makaty, Honain;
Ali, Zainab

Publication type:

journal article

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231179684

By:

Papageorgiou, Loula;
Hetjens, Svetlana;
Fareed, Jawed;
Auge, Sanny;
Tredler, Laetitia;
Harenberg, Job;
Weiss, Christel;
Elalamy, Ismail;
Gerotziafas, Grigorios T.

Publication type:

Article

Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221084307

By:

Örd, Lenna;
Marandi, Toomas;
Märk, Marit;
Raidjuk, Leonid;
Kostjuk, Jelena;
Banys, Valdas;
Krause, Karit;
Pikta, Marika

Publication type:

Article

Prevention of nNon-Vitamin K Oral Anticoagulants-Related Gastrointestinal Bleeding With Acid Suppressants: A Systematic Review and Meta-Analysis.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296211064897

By:

Dong, Yongqi;
He, Song;
Li, Xue;
Zhou, Zhihang

Publication type:

Article

The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211044722

By:

Li, Hongxia;
Zhang, Lei;
Xia, Ming;
Zhang, Chi;
Jiang, Tingbo

Publication type:

Article